E. Katarzyna Jagusztyn-Krynicka
  • Department of Bacterial Genetics, Institute of Microbiology, Faculty of Biology, University of Warsaw, Poland
研究方向
  • Microbiology
个人信息

Education

Ph. D., University of Warsaw, for thesis "Repair of damage in DNA molecules caused by disintegration of incorporated into DNA radiophosphorus atoms", 1974

Current position

Full Professor, University of Warsaw (since 2004)

Publications (since 2010)

  1. Kobierecka, P. A., Olech, B., Ksiazek, M., Derlatka, K., Adamska, I., Majewski, P. M., Jagusztyn-Krynicka, E. K. and Wyszynska, A. K. (2016). Cell Wall Anchoring of the Campylobacter Antigens to Lactococcus lactis. Front Microbiol 7: 165.
  2. Bocian-Ostrzycka, K. M., Grzeszczuk, M. J., Dziewit, L. and Jagusztyn-Krynicka, E. K. (2015). Diversity of the Epsilonproteobacteria Dsb (disulfide bond) systems. Front Microbiol 6: 570.
  3. Kobierecka, P., Wyszynska, A., Maruszewska, M., Wojtania, A., Zylinska, J., Bardowski, J. and Jagusztyn-Krynicka, E. K. (2015). Lactic acid bacteria as a surface display platform for Campylobacter jejuni antigens. J Mol Microbiol Biotechnol 25(1): 1-10.
  4. Roszczenko, P., Grzeszczuk, M., Kobierecka, P., Wywial, E., Urbanowicz, P., Wincek, P., Nowak, E. and Jagusztyn-Krynicka, E. K. (2015). Helicobacter pylori HP0377, a member of the Dsb family, is an untypical multifunctional CcmG that cooperates with dimeric thioldisulfide oxidase HP0231. BMC Microbiol 15: 135.
  5. Bocian-Ostrzycka, K. M., Lasica, A. M., Dunin-Horkawicz, S., Grzeszczuk, M. J., Drabik, K., Dobosz, A. M., Godlewska, R., Nowak, E., Collet, J. F. and Jagusztyn-Krynicka, E. K. (2015). Functional and evolutionary analyses of Helicobacter pylori HP0231 (DsbK) protein with strong oxidative and chaperone activity characterized by a highly diverged dimerization domain. Front Microbiol 6: 1065.
  6. Laniewski, P., Kuczkowski, M., Chrzastek, K., Wozniak, A., Wyszynska, A., Wieliczko, A. and Jagusztyn-Krynicka, E. K. (2014). Evaluation of the immunogenicity of Campylobacter jejuni CjaA protein delivered by Salmonella enterica sv. Typhimurium strain with regulated delayed attenuation in chickens. World J Microbiol Biotechnol 30(1): 281-292.
  7. Grabowska, A. D., Wywial, E., Dunin-Horkawicz, S., Lasica, A. M., Wosten, M. M., Nagy-Staron, A., Godlewska, R., Bocian-Ostrzycka, K., Pienkowska, K., Laniewski, P., Bujnicki, J. M., van Putten, J. P. and Jagusztyn-Krynicka, E. K. (2014). Functional and bioinformatics analysis of two Campylobacter jejuni homologs of the thiol-disulfide oxidoreductase, DsbA. PLoS One 9(9): e106247.
  8. Roszczenko, P., Radomska, K. A., Wywial, E., Collet, J. F. and Jagusztyn-Krynicka, E. K. (2012). A novel insight into the oxidoreductase activity of Helicobacter pylori HP0231 protein. PLoS One 7(10): e46563.
  9. Grabowska, A. D., Wandel, M. P., Lasica, A. M., Nesteruk, M., Roszczenko, P., Wyszynska, A., Godlewska, R. and Jagusztyn-Krynicka, E. K. (2011). Campylobacter jejuni dsb gene expression is regulated by iron in a Fur-dependent manner and by a translational coupling mechanism. BMC Microbiol 11: 166.
  10. Adamczyk-Poplawska, M., Markowicz, S. and Jagusztyn-Krynicka, E. K. (2011). Proteomics for development of vaccine. J Proteomics 74(12): 2596-2616.
  11. Lasica, A. M., Wyszynska, A., Szymanek, K., Majewski, P. and Jagusztyn-Krynicka, E. K. (2010). Campylobacter protein oxidation influences epithelial cell invasion or intracellular survival as well as intestinal tract colonization in chickens. J Appl Genet 51(3): 383-393.
  12. Jagusztyn-Krynicka, E. K., Laniewski, P. and Wyszynska, A. (2009). Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis. Expert Rev Vaccines 8(5): 625-645.
  13. Godlewska, R., Wisniewska, K., Pietras, Z. and Jagusztyn-Krynicka, E. K. (2009). Peptidoglycan-associated lipoprotein (Pal) of Gram-negative bacteria: function, structure, role in pathogenesis and potential application in immunoprophylaxis. FEMS Microbiol Lett 298(1): 1-11.
  14. Jagusztyn-Krynicka, E. K., Dadlez, M., Grabowska, A. and Roszczenko, P. (2009). Proteomic technology in the design of new effective antibacterial vaccines. Expert Rev Proteomics 6(3): 315-330.